Cargando…
Circulating Exosomal CircMYC Is Associated with Recurrence and Bortezomib Resistance in Patients with Multiple Myeloma
OBJECTIVE: Studies have shown that serum circRNA can be used as a biomarker for many tumors. However, the role of exosomal circRNA in prognostic evaluation in patients with multiple myeloma (MM) remains unclear. In this study, we aimed to analyze the role of circulating exosomal circMYC in the relap...
Autores principales: | Luo, Yanwei, Gui, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702652/ https://www.ncbi.nlm.nih.gov/pubmed/32812415 http://dx.doi.org/10.4274/tjh.galenos.2020.2020.0243 |
Ejemplares similares
-
Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells
por: Luo, Yanwei, et al.
Publicado: (2020) -
Upregulation of circ_0000199 in circulating exosomes is associated with survival outcome in OSCC
por: Luo, Yanwei, et al.
Publicado: (2020) -
CircMYC promotes proliferation, migration, invasion and inhibits apoptosis of small cell lung cancer by targeting miR-145/ Matrix Metallopeptidase 2 axis
por: Yang, Xi, et al.
Publicado: (2022) -
Exosomal mRNAs and lncRNAs involved in multiple myeloma resistance to bortezomib
por: Tang, Ju‐xian, et al.
Publicado: (2021) -
Bortezomib in the management of multiple myeloma
por: Laubach, Jacob P, et al.
Publicado: (2009)